We observed that cancer hallmarks such as allograft rejection, coagulation, epithelial–mesenchymal transition, inflammatory response, and TNFA signaling via NFKB were all enriched in the low score group (Figure 6(f)). The gene discussed is TNF; the disease is cancer.